ELUTELUTIA INC.

Nasdaq aziyo.com


$ 2.91 $ 0.02 (0.69 %)    

Monday, 06-May-2024 15:56:07 EDT
QQQ $ 439.55 $ -0.26 (-0.06 %)
DIA $ 390.50 $ 1.74 (0.45 %)
SPY $ 517.10 $ 0.05 (0.01 %)
TLT $ 90.18 $ -0.55 (-0.61 %)
GLD $ 213.58 $ -0.63 (-0.29 %)
$ 2.92
$ 2.91
$ 0.00 x 0
$ 0.00 x 0
$ 2.91 - $ 2.91
$ 1.10 - $ 4.19
7,848
na
53.03M
$ 0.26
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-11-2024 12-31-2023 10-K
2 11-14-2023 09-30-2023 10-Q
3 08-14-2023 06-30-2023 10-Q
4 05-12-2023 03-31-2023 10-Q
5 03-23-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 08-15-2022 06-30-2022 10-Q
8 05-10-2022 03-31-2022 10-Q
9 03-08-2022 12-31-2021 10-K
10 11-10-2021 09-30-2021 10-Q
11 08-10-2021 06-30-2021 10-Q
12 05-07-2021 03-31-2021 10-Q
13 03-15-2021 12-31-2020 10-K
14 11-20-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 recap-elutia-q4-earnings
Recap: Elutia Q4 Earnings
03/07/2024 21:25:17

 elutia-q4-2023-gaap-eps-0660-misses-0280-estimate-sales-5875m-miss-6550m-estimate

Elutia (NASDAQ:ELUT) reported quarterly losses of $(0.660) per share which missed the analyst consensus estimate of $(0.280) by...

 earnings-scheduled-for-march-7-2024

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on rev...

 preview-elutias-earnings
Preview: Elutia's Earnings
03/06/2024 19:01:22

 elutia-submits-cangaroorm-antibiotic-eluting-biomatrix-for-fda-clearance-510k-filing-follows-fda-feedback-from-successful-pre-submission-meeting

Elutia Inc. (NASDAQ:ELUT) today announced it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administra...

 where-elutia-stands-with-analysts
Where Elutia Stands With Analysts
11/14/2023 21:00:21

 cantor-fitzgerald-maintains-overweight-on-elutia-lowers-price-target-to-6

Cantor Fitzgerald analyst Ross Osborn maintains Elutia (NASDAQ:ELUT) with a Overweight and lowers the price target from $8 t...

 elutia-q3-earnings-insights
Elutia: Q3 Earnings Insights
11/13/2023 21:20:27

 elutia-q3-eps-050-beats-054-estimate-sales-613m-miss-730m-estimate

Elutia (NASDAQ:ELUT) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate of $(0.54) by 7.4...

 earnings-scheduled-for-november-13-2023

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr...

 earnings-outlook-for-elutia
Earnings Outlook For Elutia
11/10/2023 18:01:40

 elutia-completes-divestiture-of-orthobiologics-business-unit-for-cash-proceeds-of-up-to-35m

- Company Now Focused on Proprietary Drug-Eluting Biomatrix Platform -SILVER SPRING, Md., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Elu...

 lake-street-initiates-coverage-on-elutia-with-buy-rating-announces-price-target-of-3

Lake Street analyst Frank Takkinen initiates coverage on Elutia (NASDAQ:ELUT) with a Buy rating and announces Price Target o...

 cantor-fitzgerald-reiterates-overweight-on-elutia-maintains-8-price-target

Cantor Fitzgerald analyst Ross Osborn reiterates Elutia (NASDAQ:ELUT) with a Overweight and maintains $8 price target.

 why-flux-power-shares-are-trading-lower-by-15-here-are-other-stocks-moving-in-fridays-mid-day-session

Gainers MicroAlgo Inc. (NASDAQ: MLGO) shares jumped 74% to $7.02 after it unveiled a knowledge-enhanced backtracking search a...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION